US EditionPublished • loading... • Updated
Lisa Jarvis: The FDA’s mifepristone decision has baffled both sides
Summary by Hastings Tribune
1 Articles
1 Articles
Lisa Jarvis: The FDA’s mifepristone decision has baffled both sides
The Food and Drug Administration’s recent approval of a second generic version of the abortion pill mifepristone has left people on both sides of the reproductive rights fight scrambling to interpret the decision. Could this be a sign that the…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
